Cambridge Healthtech Institute’s 2nd Annual
mRNA Design & Delivery
Increased Efficacy, Better Stability, Targeted Delivery, Improved Safety
March 13-14, 2024
The success of messenger RNA (mRNA) vaccines to fight the SARS-CoV-2 pandemic has spurred interest in pursuing mRNA as a therapy for diseases like cancer, rare genetic disorders, autoimmunity, and more. The development timeline for mRNA drugs can be faster than small molecules, however, challenges need to be addressed before it can make it to the market. Cambridge Healthtech Institute’s conference on mRNA Design & Delivery focuses on the efforts that are underway to modify and deliver mRNA in ways that make it more efficacious, safe, and targeted for diverse disease indications.